We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.00 | 0.24% | 1,644.50 | 1,644.00 | 1,645.00 | 1,647.50 | 1,634.00 | 1,638.50 | 1,199,211 | 14:58:41 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.66 | 67.33B |
TIDMGSK
RNS Number : 8831F
GlaxoSmithKline PLC
22 May 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr R G Connor ==== ===================================== ================================================== b) Position/status President, Global Manufacturing & Supply ==== ===================================== ================================================== c) Initial notification/ Initial Notification amendment ==== ===================================== ================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ===================================== ================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================== b) Nature of the The sale of 16,065 Ordinary Shares on transaction 19 May 2017 at a price of GBP16.4227. ==== ===================================== ================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ======================== ===================== GBP16.4227 16,065 =================================================================== ===================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================ ============================ e) Date of the transaction 2017-05-19 ==== ===================================== ================================================== f) Place of the transaction London Stock Exchange (XLON) ==== ===================================== ================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mrs D Connor ==== ===================================== ================================================== b) Position/status PCA of Mr R G Connor (President, Global Manufacturing & Supply) ==== ===================================== ================================================== c) Initial notification/ Initial Notification amendment ==== ===================================== ================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ===================================== ================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================== b) Nature of the The sale of 7,435 Ordinary Shares on 19 transaction May 2017 at a price of GBP16.4153. ==== ===================================== ================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ======================== ===================== GBP16.4153 7,435 =================================================================== ===================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================ ============================ e) Date of the transaction 2017-05-19 ==== ===================================== ================================================== f) Place of the transaction London Stock Exchange (XLON) ==== ===================================== ==================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHELLFLDEFXBBK
(END) Dow Jones Newswires
May 22, 2017 11:40 ET (15:40 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions